Kevin Lockett
Kevin is a graduate of Kansas State University, where he also participated as a three-time All-American Division I athlete. He was drafted in the second round of the 1997 NFL draft and retired after a seven-year career. Kevin was elected to a nine-year term on the Kansas State University Foundation Board of Directors and recently completed his service. He holds a bachelor's degree in accounting.
Kevin also serves as a board member of INTRUST Bank, the United Way of Greater Kansas City, Kansas City University of Medicine and Biosciences, and the Kansas State Golf Course Management and Research Foundation.
Kevin is a partner of Fulcrum Global Capital, a VC firm based in Kansas City focused on partnering with entrepreneurs who are attacking the global food and healthcare markets, bringing nearly 20 years of experience in financing, managing, growing and investing in early-stage companies to his role.
Previously, Kevin was President/CEO of the Kansas Bioscience Authority (KBA), the organization established by the state legislature in 2004 to develop bioscience as an economic engine for the state of Kansas. Most recently, the KBA operated as a venture capital investor with a focus on industry sectors where Kansas has conspicuous advantages: agribusiness, animal health, human health, and life sciences tech.
Before KBA, Kevin worked for a decade at the Ewing Marion Kauffman Foundation, a $2 billion private foundation consulting nationwide to advance education and entrepreneurship. The majority of his activities centered on leading a Kauffman Foundation spinout focused on providing management consulting services to entrepreneurs across the country.
Professionally and personally, Kevin is interested in how we, as a country and globally, will manage to feed and care for ourselves as the global population swells and socioeconomic demographics change.
As a member of Class 21, Kevin served his fellowship under the mentorship of Duane Cantrell (Mentor Class 20), Managing Partner at Fulcrum Global Capital. He spent the first part of his fellowship at the Kansas Bioscience Authority, and completed it at Fulcrum Global Capital.